Ascension Orthopedics, a medical device company focusing on the lower and upper extremities, will represent approximately 45 percent of Integra’s orthopedics revenue. The company will make a significant contribution to Integra’s upper extremity and shoulder portfolio.
The acquisition also means Ascensions’ differentiated pyrolytic carbon technology will be brought to Integra. The company’s PyroCarbon is a specific form of carbon with manufactured crystalline structures for enhanced strength and wear characteristics.
Over the last 12 months ending in June, Ascension generated approximately $19 million.
Related Articles on Orthopedic Device Companies:
42 Orthopedic and Spine Devices Receive FDA 510(k) Clearance in August
MedShape Solutions Receives Small Business Innovation Research Grant
Zimmer Supports Orthopedic Mission Trip to Nigeria
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.